AIMS: Systematic review of mortality in childhood-/adolescent-diagnosed Type 1 diabetes and examination of factors explaining the mortality variation between studies. METHODS: Relevant studies were identified from systematic searches of MEDLINE and EMBASE. Observed and expected numbers of deaths were extracted, and standardised mortality ratios (SMRs) and 95 % confidence intervals (CIs) were calculated. Negative binomial regression was used to investigate association between mortality and study/country characteristics. RESULTS: Thirteen relevant publications with mortality data were identified describing 23 independent studies. SMRs varied markedly ranging from 0 to 854 (χ (2) = 70.68, df = 21, P < 0.0001). Significant associations were observed between SMR and mid-year of follow-up [incidence rate ratio (IRR) 0.95, 95 % CI 0.91-0.99 equivalent to a 5 % decrease per year], between SMR and infant mortality rate (IRR 1.07, 95 % CI 1.02-1.12, a 7 % increase for each death per 1,000 live births) and, after omitting an outlier, between SMR and health expenditure as a percentage of gross domestic product (GDP) (IRR 0.79, 95 % CI 0.68-0.93, a 21 % decrease for each one percent increase in GDP). No relationship was detected between SMR and a country's childhood diabetes incidence rate or GDP. CONCLUSIONS: Excess mortality in childhood-/adolescent-diagnosed Type 1 diabetes is apparent across countries worldwide. Excesses were less marked in more recent studies and in countries with lower infant mortality and higher health expenditure.
AIMS: Systematic review of mortality in childhood-/adolescent-diagnosed Type 1 diabetes and examination of factors explaining the mortality variation between studies. METHODS: Relevant studies were identified from systematic searches of MEDLINE and EMBASE. Observed and expected numbers of deaths were extracted, and standardised mortality ratios (SMRs) and 95 % confidence intervals (CIs) were calculated. Negative binomial regression was used to investigate association between mortality and study/country characteristics. RESULTS: Thirteen relevant publications with mortality data were identified describing 23 independent studies. SMRs varied markedly ranging from 0 to 854 (χ (2) = 70.68, df = 21, P < 0.0001). Significant associations were observed between SMR and mid-year of follow-up [incidence rate ratio (IRR) 0.95, 95 % CI 0.91-0.99 equivalent to a 5 % decrease per year], between SMR and infant mortality rate (IRR 1.07, 95 % CI 1.02-1.12, a 7 % increase for each death per 1,000 live births) and, after omitting an outlier, between SMR and health expenditure as a percentage of gross domestic product (GDP) (IRR 0.79, 95 % CI 0.68-0.93, a 21 % decrease for each one percent increase in GDP). No relationship was detected between SMR and a country's childhood diabetes incidence rate or GDP. CONCLUSIONS: Excess mortality in childhood-/adolescent-diagnosed Type 1 diabetes is apparent across countries worldwide. Excesses were less marked in more recent studies and in countries with lower infant mortality and higher health expenditure.
Authors: Chiara Mameli; Sara Mazzantini; Moufida Ben Nasr; Paolo Fiorina; Andrea E Scaramuzza; Gian Vincenzo Zuccotti Journal: World J Diabetes Date: 2015-07-10
Authors: German Tapia; Karl Mårild; Sandra R Dahl; Nicolai A Lund-Blix; Marte K Viken; Benedicte A Lie; Pål R Njølstad; Geir Joner; Torild Skrivarhaug; Arieh S Cohen; Ketil Størdal; Lars C Stene Journal: Diabetes Care Date: 2019-01-28 Impact factor: 19.112
Authors: Michael Fleming; Catherine A Fitton; Markus F C Steiner; James S McLay; David Clark; Albert King; Robert S Lindsay; Daniel F Mackay; Jill P Pell Journal: Diabetes Care Date: 2019-07-15 Impact factor: 19.112
Authors: Rachel G Miller; Hemant D Mahajan; Tina Costacou; Akira Sekikawa; Stewart J Anderson; Trevor J Orchard Journal: Diabetes Care Date: 2016-09-21 Impact factor: 19.112
Authors: Jing W Hughes; Yicheng K Bao; Maamoun Salam; Prajesh Joshi; C Rachel Kilpatrick; Kavita Juneja; David Nieves; Victoria Bouhairie; Olivia J Jordan; Erica C Blustein; Garry S Tobin; Janet B McGill Journal: Diabetes Care Date: 2018-10-25 Impact factor: 19.112
Authors: M Loredana Marcovecchio; Päivi H Tossavainen; Katharine Owen; Catherine Fullah; Paul Benitez-Aguirre; Stefano Masi; Ken Ong; Helen Nguyen; Scott T Chiesa; R Neil Dalton; John Deanfield; David B Dunger Journal: Pediatr Diabetes Date: 2017-03-08 Impact factor: 4.866
Authors: Jean M Lawrence; Kristi Reynolds; Sharon H Saydah; Amy Mottl; Catherine Pihoker; Dana Dabelea; Lawrence Dolan; Leora Henkin; Angela D Liese; Scott Isom; Jasmin Divers; Lynne Wagenknecht Journal: Diabetes Care Date: 2021-10-04 Impact factor: 19.112
Authors: Kristi Reynolds; Sharon H Saydah; Scott Isom; Jasmin Divers; Jean M Lawrence; Dana Dabelea; Elizabeth J Mayer-Davis; Giuseppina Imperatore; Ronny A Bell; Richard F Hamman Journal: J Diabetes Complications Date: 2018-04-04 Impact factor: 3.219